Table 1.

Presenting characteristics by BAALC expression group




Low BAALC n = 43

High BAALC n = 43

P
Age, y, median (range)   48 (20-59)   45 (18-59)   .21  
Sex, n (% males)   24 (56)   22 (51)   .83  
Hemoglobin level, g/dL, median (range)   8.95 (4.7-12.8)   8.7 (4.6-12.9)   .84  
Platelet count, ×109/L, median (range)   50 (5-311)   61 (7-378)   .71  
WBC, ×109/L, median (range)   31.6 (1.4-295.0)   13.8 (0.8-96.5)   .03  
Percent blood blasts, median (range)   53 (0-97)   46 (0-95)   .33  
Percent bone marrow blasts, median (range)   58 (28-90)   55 (26-90)   .46  
Race, n (%)     .10  
    White   35 (81)   40 (93)   
    Hispanic   6 (14)   1 (2)   
    African American   1 (2)   1 (2)   
    Oriental   1 (2)   0 (0)   
    Other   0 (0)   1 (2)   
FAB classification, n (%)     .03  
    M0   1 (2)   2 (5)   
    M1   7 (17)   11 (28)   
    M2   12 (29)   16 (40)   
    M4   12 (29)   9 (23)   
    M5   10 (24)   1 (3)   
    M6   0 (0)   1 (3)   
    Unknown   1   3   
Gum hypertrophy, n (%)   10 (23)   6 (14)   .41  
Lymphadenopathy, n (%)   3 (7)   5 (12)   .71  
Skin infiltrates, n (%)   8 (19)   3 (7)   .20  
Hepatomegaly, n (%)   2 (5)   2 (5)   .99  
Splenomegaly, n (%)   1 (2)   4 (9)   .36  
FLT3 genotype, n (%)     
    FLT3WT/WT  35 (81)   35 (81)   .99  
    FLT3ITD/WT
 
8 (19)
 
8 (19)
 

 



Low BAALC n = 43

High BAALC n = 43

P
Age, y, median (range)   48 (20-59)   45 (18-59)   .21  
Sex, n (% males)   24 (56)   22 (51)   .83  
Hemoglobin level, g/dL, median (range)   8.95 (4.7-12.8)   8.7 (4.6-12.9)   .84  
Platelet count, ×109/L, median (range)   50 (5-311)   61 (7-378)   .71  
WBC, ×109/L, median (range)   31.6 (1.4-295.0)   13.8 (0.8-96.5)   .03  
Percent blood blasts, median (range)   53 (0-97)   46 (0-95)   .33  
Percent bone marrow blasts, median (range)   58 (28-90)   55 (26-90)   .46  
Race, n (%)     .10  
    White   35 (81)   40 (93)   
    Hispanic   6 (14)   1 (2)   
    African American   1 (2)   1 (2)   
    Oriental   1 (2)   0 (0)   
    Other   0 (0)   1 (2)   
FAB classification, n (%)     .03  
    M0   1 (2)   2 (5)   
    M1   7 (17)   11 (28)   
    M2   12 (29)   16 (40)   
    M4   12 (29)   9 (23)   
    M5   10 (24)   1 (3)   
    M6   0 (0)   1 (3)   
    Unknown   1   3   
Gum hypertrophy, n (%)   10 (23)   6 (14)   .41  
Lymphadenopathy, n (%)   3 (7)   5 (12)   .71  
Skin infiltrates, n (%)   8 (19)   3 (7)   .20  
Hepatomegaly, n (%)   2 (5)   2 (5)   .99  
Splenomegaly, n (%)   1 (2)   4 (9)   .36  
FLT3 genotype, n (%)     
    FLT3WT/WT  35 (81)   35 (81)   .99  
    FLT3ITD/WT
 
8 (19)
 
8 (19)
 

 
Close Modal

or Create an Account

Close Modal
Close Modal